Optimizing antimicrobial drug dosing in critically ill patients
Funding Information: Conflicts of Interest: P.P. has received lecture fees and advisory board from MSD, Gilead, Pfizer; L.C. and P.M. declared no conflicts of interest related to the underlying topics; J.G.P. received unre‐ stricted research grants from Merck Sharp and Dohme; received lecture and ad...
| Autor principal: | |
|---|---|
| Outros Autores: | , , |
| Formato: | review |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10362/121296 |
| País: | Portugal |
| Oai: | oai:run.unl.pt:10362/121296 |